drugset / Trial / NCT01086410
Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the effect of six weeks' treatment with two once-daily strengths of Fluticasone Furoate/GW642444 Inhalation Powder on the HPA axis system
Timeline
- Start
- 2010-03
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone Furoate/GW642444 | Unknown | — | Inhaled |
| Comparator | Prednisolone | Other / unclassified | 10 mg | Oral |